首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1620332

全球术后疼痛治疗药物市场规模：依药物类别、给药途径、分销管道、地区、范围和预测

Global Postoperative Pain Therapeutics Market Size By Drug Class, By Route Of Administration, By Distribution Channel, By Geographic Scope And Forecast

出版日期: 2024年10月20日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

术后疼痛治疗药物市场规模及预测

2023年术后疼痛治疗市场规模为121.6亿美元，预计2024年至2031年复合年增长率为3.89%，到2031年预计将达到164.9亿美元。术后止痛药物是指控制患者在手术后所经历的疼痛的医疗介入和治疗。术后止痛药旨在减轻疼痛、促进癒合併改善术后整体復原。此类治疗包括各种药理学和非药理学技术，以适应每位患者的特定需求和所进行的手术类型。

鸦片类药物、非类固醇类抗发炎药 (NSAID) 和局部麻醉药是药物治疗中常用的止痛药。非药物治疗包括物理治疗、针灸和放鬆练习。

此外，术后止痛药广泛用于各种医学专业和外科手术，从小型门诊手术到更具侵入性的手术。

术后疼痛治疗药物市场动态

塑造术后疼痛治疗市场的关键市场动态

主要市场推动因素

手术技术的提升：

由于人口老化、慢性疾病和外科手术技术的发展，全世界外科手术的增加增加了术后止痛药物以有效控制术后疼痛的需求。

关于疼痛管理的看法和期望：

患者和医疗保健专业人员越来越意识到适当疼痛管理的必要性。因此，患者对舒适恢復时间的期望增加，从而增加了对先进术后止痛药物的需求。

药品创新及审核：

新的有效疼痛治疗方法（包括非鸦片类药物替代品）的开发和批准是一个重要的驱动力。药物传递系统的创新也推动了市场的发展，这些创新可以提供更长时间的疼痛缓解且副作用最小。

政府与医疗政策：

鼓励医疗机构实施有效疼痛管理标准的政府法规和指南刺激了先进治疗药物的使用。有利于疼痛管理药物和治疗的报销法规正在推动术后止痛药物市场的发展。

主要课题

鸦片类药物危机与监管：

由于鸦片类药物危机，有关鸦片类药物处方的法律变得更加严格，为市场参与者设置了障碍。对非鸦片类止痛药的需求不断增长，但开发与鸦片类药物一样有效的替代品却很复杂。

止痛药物的副作用：

许多术后镇痛药物有噁心、呕吐和便秘等副作用，并且可能引起毒性，因此不鼓励使用。开发副作用较少的药物也是市场开发的重要课题。

临床和监管障碍：

将创新的疼痛管理产品推向市场需要广泛的临床试验和监管部门的批准。这些过程既耗时又昂贵，为新药物和技术进入术后疼痛治疗市场设置了重大障碍。

主要趋势：

对非鸦片类药物的需求不断增长：

对鸦片类药物成瘾的担忧正在推动人们转向非鸦片类药物治疗。因此，製药公司正在开发非成瘾性疼痛管理治疗方法，可以有效治疗术后疼痛，且没有鸦片类药物的风险。

多模式疼痛管理的兴起：

"多模式疼痛管理" 结合了多种方法和药物来治疗疼痛，在市场上越来越受欢迎。此方法旨在改善疼痛缓解并最大限度地减少副作用，从而加快患者康復速度并缩短住院时间。

门诊手术中心的成长：

由于门诊手术中心 (ASC) 的发展，对有效的术后止痛药物的需求量很大。ASC 为医院手术提供了一种经济高效的替代方案，专注于缩短患者康復时间并增强疼痛管理方案。

药物输送系统的进展：

为了提高术后疼痛管理的有效性和便利性，人们越来越重视开发新的药物传递系统，例如透皮贴片和植入装置。这些技术可调节药物的释放，因此无需频繁给药即可持续缓解疼痛。

术后疼痛治疗药物市场的区域分析

术后疼痛治疗药物市场的详细区域分析

北美：

根据验证市场研究，预计北美将在预测期内主导术后疼痛治疗药物市场。北美由于其先进的医疗基础设施和患者获得医疗护理的机会而进行了大量的外科手术，这推动了对术后止痛药物的需求，以成功地管理康復。

该地区目前正经历鸦片类药物危机，非鸦片类药物疼痛治疗方案正受到广泛关注。监管机构和医疗保健利益相关者致力于寻找更安全、更有效的方法来控制术后疼痛而不助长成瘾。

北美主要製药公司和研究机构的存在推动了创新疼痛管理药物（包括非鸦片类药物和新型药物输送方法）的开发，正在推动市场成长。

此外，随着北美门诊手术中心（ASC）的扩张以及具有成本效益和高效的手术护理，术后疼痛管理选项可确保及时康復并需要加强患者满意度。

亚太地区：

在市场估计和预测期内，亚太地区预计将以最高的复合年增长率成长。亚太地区的医疗基础设施（包括医院和手术中心）正在显着增长，以适应越来越多需要适当术后疼痛治疗的外科手术。

在日本、中国和印度等国家，更容易患慢性病的老龄化人口不断增加，外科手术的需求也在增加，从而增加了对治疗术后疼痛的药物的需求。

医疗保健专业人员和患者越来越意识到适当疼痛管理的必要性，推动了该地区术后疼痛药物市场对先进治疗的需求。

此外，亚太地区的经济发展正在增加医疗保健支出和医学研究投资，促进先进术后疼痛管理方案的发展。

欧洲：

欧洲对疼痛管理药物（尤其是鸦片类药物）的使用有严格的规定，并且对创新且安全的术后疼痛治疗的需求不断增长。

欧洲每年进行大量的选择性和非选择性手术，因此对有效的术后疼痛管理解决方案的需求很高，以促进患者康復并缩短住院时间。

为了全面缓解术后疼痛，欧洲医疗保健系统越来越多地实施结合药物和非药物治疗的多模式疼痛治疗策略。

此外，欧洲医疗保健创新举措，例如创新药物输送方法和非阿片类药物的开发，透过提供有效且对患者友好的替代方案，正在推动术后疼痛治疗市场的成长。

Postoperative Pain Therapeutics Market size was valued at USD 12.16 Billion in 2023 and is projected to reach USD 16.49 Billion by 2031 , growing at a CAGR of 3.89% from 2024 to 2031. Postoperative pain therapeutics refers to medical interventions and treatments used to manage pain experienced by patients following surgical procedures. Postoperative pain therapeutics aim to reduce suffering, increase healing, and improve overall recovery after surgery. These therapeutics include a variety of pharmacological and non-pharmacological techniques that are adapted to each patient's specific needs and the type of operation performed.

Opioids, nonsteroidal anti-inflammatory medicines (NSAIDs), and local anesthetics are popular analgesics used in pharmacological therapies. Non-pharmacological therapies include physical therapy, acupuncture, and relaxation exercises.

Furthermore, postoperative pain therapeutics are used in a wide range of medical specializations and surgical procedures, from small outpatient procedures to more invasive operations.

Postoperative Pain Therapeutics Market Dynamics

The key market dynamics that are shaping the Postoperative Pain Therapeutics Market include:

Key Market Drivers

Rising Surgical Procedures:

The global increase in surgical procedures due to aging populations, chronic diseases, and technical developments in surgery techniques is driving the need for postoperative pain therapeutics to effectively manage pain after surgery.

Awareness and Expectation for Pain Management:

Patients and healthcare providers are becoming increasingly aware of the necessity of proper pain management. As a result, advanced postoperative pain therapeutics are in high demand due to rising patient expectations for comfortable recovery times.

Pharmaceutical Innovations and Approvals:

The development and approval of new and effective pain treatment medications, including non-opioid alternatives, are important drivers. Drug delivery system innovations that provide longer pain relief while minimizing negative effects also helping drive market.

Government and Healthcare Policies:

Government rules and guidelines encouraging effective pain management standards in healthcare facilities stimulate the use of sophisticated therapeutics. Reimbursement rules that favor pain management medications and therapies are propelling the Postoperative Pain Therapeutics Market.

Key Challenges:

Opioid Crisis and Regulation:

The opioid crisis has resulted in stringent opioid prescription laws, which pose hurdles for players in the market. The demand for non-opioid pain treatment solutions is growing, but creating alternatives that are as effective as opioids is complicated.

Side Effects of Pain Management Drugs:

Many postoperative pain management medicines have side effects, such as nausea, vomiting, constipation, and the potential for addiction is discouraging their usage. Developing medications with minimal side effects is also an important challenge in the market.

Clinical and Regulatory Hurdles:

Bringing innovative pain management products to market needs extensive clinical testing and regulatory authorization. These processes are time-consuming and costly, creating significant barriers to the entry of novel medications and technologies into the Postoperative Pain Therapeutics Market.

Key Trends:

Increasing Demand for Non-Opioid Medications:

Concerns about opioid addiction are driving a huge shift towards non-opioid therapies. Thus, pharmaceuticals are developing non-addictive pain management treatments that effectively cure postoperative pain without the hazards of opioids.

Rise of Multimodal Pain Management:

Multimodal pain management, which combines several approaches and drugs to treat pain, is becoming increasingly popular in the market. This method attempts to improve pain relief and minimize adverse effects, resulting in faster patient recovery and shorter hospital stays.

Growth in Ambulatory Surgical Centers:

Effective postoperative pain therapeutics are in high demand due to the growth of ambulatory surgical centers (ASCs). ASCs provide a cost-effective alternative to hospital-based surgeries, focusing on reducing patient recovery time and enhancing pain management protocols.

Advancements in Drug Delivery Systems:

There is a rising emphasis on creating novel medication delivery systems, such as transdermal patches and implanted devices, to improve the efficacy and convenience of post-operative pain management. These technologies provide regulated medication release, resulting in constant pain relief without frequent dosage.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Postoperative Pain Therapeutics Market Regional Analysis

Here is a more detailed regional analysis of the Postoperative Pain Therapeutics Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Postoperative Pain Therapeutics Market during the forecast period. North America has an important number of surgical procedures due to sophisticated healthcare infrastructure and patient access to medical care, driving the demand for postoperative pain therapeutics to successfully manage recovery.

With the present opioid crisis in this region, there is a tremendous push for non-opioid pain management alternatives. Regulatory agencies and healthcare practitioners are concentrating on safer, more effective ways to manage postoperative pain without contributing to addiction.

The presence of major pharmaceutical companies and research institutions in North America promotes the development of innovative pain management medicines, such as non-opioid medications and novel drug delivery methods is propelling the growth of the market.

Furthermore, the expansion of ambulatory surgical centers (ASCs) in North America, which provide cost-effective and efficient surgical treatment is demanding enhanced postoperative pain management options to ensure timely recovery and patient satisfaction.

Asia Pacific:

Asia Pacific is estimated to grow at the highest CAGR within the market during the forecast period. Asia Pacific is experiencing tremendous growth in healthcare infrastructure, including hospitals and surgical centers, to accommodate an increasing number of surgical procedures that necessitate adequate postoperative pain treatment.

The growing older population in countries such as Japan, China, and India, which are more prone to chronic illnesses necessitate surgical procedures, thereby boosting demand for postoperative pain therapeutics.

Healthcare professionals and patients are becoming more conscious of the necessity of appropriate pain management, driving up demand for sophisticated treatments in the Postoperative Pain Therapeutics Market in this region.

Furthermore, economic development in the Asia-Pacific region has resulted in increasing healthcare spending and medical research investments, facilitating access to the development of advanced postoperative pain management options.

Europe:

Europe's stringent regulatory framework for pain management medications, particularly opioid use, fuels demand for innovative and safer postoperative pain therapies.

With a significant number of elective and non-elective surgeries conducted each year, Europe has a high demand for efficient postoperative pain management solutions to improve patient recovery and shorten hospital stays.

To provide comprehensive pain relief following surgery, European healthcare systems are increasingly implementing multimodal pain treatment strategies that combine pharmaceutical and nonpharmacological approaches.

Furthermore, Europe's dedication to healthcare innovation, which includes the development of innovative drug delivery methods and non-opioid drugs, helps to drive market growth for postoperative pain treatments by providing effective and patient-friendly alternatives.

Postoperative Pain Therapeutics Market: Segmentation Analysis

The Global Postoperative Pain Therapeutics Market is segmented based on Drug Class, Route Of Administration, Distribution Channel, And Geography.

Postoperative Pain Therapeutics Market, By Drug Class

Opioids
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Local Anesthetics
Tricyclic Antidepressants
Antiepileptic Drugs
Others

Based on Drug Class, the market is segmented into Opioids, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Local Anesthetics, Tricyclic Antidepressants, Antiepileptic Drugs, and Others. The opioids segment is estimated to dominate the Postoperative Pain Therapeutics Market due to their effectiveness in managing moderate to severe pain. Despite increasing concerns about addiction and the search for non-opioid alternatives, opioids remain popular in the postoperative setting due to their superior efficacy in treating acute pain. Opioids are used by healthcare practitioners for acute pain treatment after surgery, especially when the intensity of the pain exceeds the analgesic capacity of NSAIDs or local anesthetics.

Postoperative Pain Therapeutics Market, By Route Of Administration

Oral
Intramuscular
Intravenous
Others

Based on the Route Of Administration, the market is segmented into Oral, Intramuscular, Intravenous, and Others. The intravenous segment is estimated to dominate the Postoperative Pain Therapeutics Market during the forecast period. The intravenous route is preferable in hospitals due to its rapid start of action, accurate dosage control, and capacity to offer continuous pain relief, all of which are critical for managing acute postoperative pain. Furthermore, intravenous delivery is extremely beneficial for individuals who are unable to take oral drugs due to postoperative restrictions or nausea. The efficiency, control, and quick comfort given by the intravenous injection make it an essential component of postoperative therapy, assuring its market domination.

Postoperative Pain Therapeutics Market, By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Based on the Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The hospital pharmacies segment is estimated to dominate the market over the forecast period. This dominance is due to hospital pharmacies' direct involvement in the patient care process, particularly during the early postoperative period. Hospital pharmacies play an important role in the healthcare delivery system, ensuring that critical pain management drugs are available quickly after surgical procedures. This segment's popularity is bolstered by the high volume of surgeries conducted in hospitals, where thorough pain management protocols are vital to patient care, making hospital pharmacies an important component of the Postoperative Pain Therapeutics Market.

Key Players

The " Global Postoperative Pain Therapeutics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
AbbVie, Johnson & Johnson, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., AstraZeneca plc, Eli Lilly and Company, GlaxoSmithKline plc, Baxter International Inc., Zimmer Biomet Holdings Inc., Boston Scientific Corporation, Medtronic plc, Stryker Corporation, Becton, Dickinson and Company, Smith & Nephew plc, and Altaris Therapeutics Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In February 2024, Pacira BioSciences announced positive findings from a Phase 3 trial of its long-acting local anaesthetic EXPAREL(R) in patients having bunionectomy surgery. The trial attained its primary goal of showing a statistically significant reduction in pain levels when compared to placebo.
In January 2024, Collegium Pharmaceutical introduced its new Xtampza ER(R) (oxycodone hydrochloride) extended-release tablets in a new 20mg dosing strength. This broadens the product portfolio for treating moderate-to-severe chronic pain.
In January 2024, Grunenthal demonstrated positive results from a Phase 2 research of its new nerve growth factor (NGF) inhibitor, Qsymia(R) (resiniferatoxin), for the treatment of post-surgical neuropathic pain. The findings revealed significant increases in pain levels and quality of life when compared to placebo.
In January 2024, Aprecia Pharmaceuticals expanded its Sprintec(R) (Aprecia Melt) line of fast-dissolving sublingual films with the introduction of Aprecia Melt Zuplenz(R) (ondansetron) for the prevention and management of nausea and vomiting associated with surgery.
In January 2024, Xeris Pharmaceuticals published findings from a Phase 2 study of GLYENA(R), a novel sustained-release local anaesthetic, for the treatment of postherpetic neuralgia. The findings revealed significant increases in pain levels and quality of life when compared to placebo.

1 INTRODUCTION OF GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET, BY DRUG CLASS

5.1 Overview
5.2 Opioids
5.3 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5.4 Local Anesthetics
5.5 Tricyclic Antidepressants
5.6 Antiepileptic Drugs
5.7 Others

6 GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

6.1 Overview
6.2 Oral
6.3 Intramuscular
6.4 Intravenous
6.5 Others

7 GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
7.5 Others

8 GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL POSTOPERATIVE PAIN THERAPEUTICS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 AbbVie
- 10.1.1 Company Overview
- 10.1.2 Company Insights
- 10.1.3 Business Breakdown
- 10.1.4 Product Benchmarking
- 10.1.5 Key Developments
- 10.1.6 Winning Imperatives
- 10.1.7 Current Focus & Strategies
- 10.1.8 Threat from Competition
- 10.1.9 SWOT Analysis
10.2 Johnson & Johnson
- 10.2.1 Company Overview
- 10.2.2 Company Insights
- 10.2.3 Business Breakdown
- 10.2.4 Product Benchmarking
- 10.2.5 Key Developments
- 10.2.6 Winning Imperatives
- 10.2.7 Current Focus & Strategies
- 10.2.8 Threat from Competition
- 10.2.9 SWOT Analysis
10.3 Pfizer Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Insights
- 10.3.3 Business Breakdown
- 10.3.4 Product Benchmarking
- 10.3.5 Key Developments
- 10.3.6 Winning Imperatives
- 10.3.7 Current Focus & Strategies
- 10.3.8 Threat from Competition
- 10.3.9 SWOT Analysis
10.4 Teva Pharmaceutical Industries Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Insights
- 10.4.3 Business Breakdown
- 10.4.4 Product Benchmarking
- 10.4.5 Key Developments
- 10.4.6 Winning Imperatives
- 10.4.7 Current Focus & Strategies
- 10.4.8 Threat from Competition
- 10.4.9 SWOT Analysis
10.5 Novartis AG
- 10.5.1 Company Overview
- 10.5.2 Company Insights
- 10.5.3 Business Breakdown
- 10.5.4 Product Benchmarking
- 10.5.5 Key Developments
- 10.5.6 Winning Imperatives
- 10.5.7 Current Focus & Strategies
- 10.5.8 Threat from Competition
- 10.5.9 SWOT Analysis
10.6 Merck & Co. Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Insights
- 10.6.3 Business Breakdown
- 10.6.4 Product Benchmarking
- 10.6.5 Key Developments
- 10.6.6 Winning Imperatives
- 10.6.7 Current Focus & Strategies
- 10.6.8 Threat from Competition
- 10.6.9 SWOT Analysis
10.7 F. Hoffmann-La Roche Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Insights
- 10.7.3 Business Breakdown
- 10.7.4 Product Benchmarking
- 10.7.5 Key Developments
- 10.7.6 Winning Imperatives
- 10.7.7 Current Focus & Strategies
- 10.7.8 Threat from Competition
- 10.7.9 SWOT Analysis
10.8 AstraZeneca plc
- 10.8.1 Company Overview
- 10.8.2 Company Insights
- 10.8.3 Business Breakdown
- 10.8.4 Product Benchmarking
- 10.8.5 Key Developments
- 10.8.6 Winning Imperatives
- 10.8.7 Current Focus & Strategies
- 10.8.8 Threat from Competition
- 10.8.9 SWOT Analysis
10.9 Eli Lilly and Company
- 10.9.1 Company Overview
- 10.9.2 Company Insights
- 10.9.3 Business Breakdown
- 10.9.4 Product Benchmarking
- 10.9.5 Key Developments
- 10.9.6 Winning Imperatives
- 10.9.7 Current Focus & Strategies
- 10.9.8 Threat from Competition
- 10.9.9 SWOT Analysis
10.10 GlaxoSmithKline plc
- 10.10.1 Company Overview
- 10.10.2 Company Insights
- 10.10.3 Business Breakdown
- 10.10.4 Product Benchmarking
- 10.10.5 Key Developments
- 10.10.6 Winning Imperatives
- 10.10.7 Current Focus & Strategies
- 10.10.8 Threat from Competition
- 10.10.9 SWOT Analysis

11 KEY DEVELOPMENTS

11.1 Product Launches/Developments
11.2 Mergers and Acquisitions
11.3 Business Expansions
11.4 Partnerships and Collaborations

12 Appendix

12.1 Related Research

02-2729-4219

+886-2-2729-4219

License/价格

全球术后疼痛治疗药物市场规模：依药物类别、给药途径、分销管道、地区、范围和预测

Global Postoperative Pain Therapeutics Market Size By Drug Class, By Route Of Administration, By Distribution Channel, By Geographic Scope And Forecast

术后疼痛治疗药物市场规模及预测

术后疼痛治疗药物市场动态

主要市场推动因素

术后疼痛治疗药物市场的区域分析

目录

第1章全球术后疼痛治疗药物市场：简介

第 2 章执行摘要

第3章 验证市场研究研究方法

第4章 全球术后疼痛治疗药物市场展望

第5章全球术后疼痛治疗药物市场：依药物类别

第6章全球术后疼痛治疗市场：依给药途径分类

第7章全球术后疼痛治疗药物市场：依通路划分

第8章全球术后疼痛治疗药物市场：按地区

第9章 全球术后疼痛治疗药物市场：竞争格局

第10章 公司简介

第11章 主要进展

第12章附录

Postoperative Pain Therapeutics Market Size And Forecast